Effectiveness of a third dose of MMR vaccine for mumps outbreak control

New England Journal of Medicine

Volumn 377, Issue 10, 2017, Pages 947-956

  Cardemil, Cristina V ^a   Dahl, Rebecca M ^b   James, Lisa ^c   Wannemuehler, Kathleen ^a   Gary, Howard E ^a   Shah, Minesh ^a   Marin, Mona ^a   Riley, Jacob ^d   Feikin, Daniel R ^a   Patel, Manisha ^a   Quinlisk, Patricia ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Maximus Federal   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Johnson County Public Health   (United States)

^e IOWA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EPIDEMIC; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION CONTROL; INFECTION RISK; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; RUBELLA; SCHOOL CHILD; UNIVERSITY STUDENT; YOUNG ADULT; DISEASE OUTBREAKS; FEMALE; IMMUNOLOGY; IOWA; MALE; PROPORTIONAL HAZARDS MODEL; RISK; SECONDARY IMMUNIZATION; STUDENT; UNIVERSITY;

ADOLESCENT; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IOWA; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; PROPORTIONAL HAZARDS MODELS; RISK; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 85029230699     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1703309     Document Type: Article

References (27)

1. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-04): 1-34.
2. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009; 27: 6186-95.
3. Barskey AE, Schulte C, Rosen JB, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012; 367: 1704-13.
4. Morbidity and Mortality Weekly Report (MMWR) notifiable diseases and mortality tables (http://www .cdc .gov/ mmwr/ publications/ index .html).
5. Albertson JP, Clegg WJ, Reid HD, et al. Mumps outbreak at a university and recommendation for a third dose of measles- mumps-rubella vaccine - Illinois, 2015- 2016. MMWR Morb Mortal Wkly Rep 2016; 65: 731-4.
6. Mumps outbreak on a university campus - California, 2011. MMWR Morb Mortal Wkly Rep 2012; 61: 986-9.
7. Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13: 12-7.
8. LeBaron CW, Forghani B, Beck C, et al. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 2009; 199: 552-60.
9. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46: 1172-80.
10. Vygen S, Fischer A, Meurice L, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Euro Surveill 2016; 21: 30156.
11. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year followup. J Infect Dis 2008; 197: 950-6.
12. Rubin S, Kennedy R, Poland G. Emerging mumps infection. Pediatr Infect Dis J 2016; 35: 799-801.
13. Deeks SL, Lim GH, Simpson MA, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ 2011; 183: 1014-20.
14. Schaffzin JK, Pollock L, Schulte C, et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 2007; 120(4): E862-e868.
15. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: Are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008; 47: 1458-67
16. Nelson GE, Aguon A, Valencia E, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumpsrubella vaccine for outbreak control - Guam 2009 to 2010. Pediatr Infect Dis J 2013; 32: 374-80.
17. Ogbuanu IU, Kutty PK, Hudson JM, et al. Impact of a third dose of measlesmumps-rubella vaccine on a mumps outbreak. Pediatrics 2012; 130(6): E1567-74.
18. Kutty PK, Lawler J, Rausch-Phung E, et al. Epidemiology and the economic as- sessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010. Hum Vaccin Immunother 2014; 10: 1373-81.
19. Mahamud A, Fiebelkorn AP, Nelson G, et al. Economic impact of the 2009-2010 Guam mumps outbreak on the public health sector and affected families. Vaccine 2012; 30: 6444-8.
20. Shah M, Cardemil CV, Weigel A, et al. Mumps outbreak characterization before and after a 3rd dose MMR vaccination campaign in a large university, Iowa, July 2015-April 2016. Open Forum Infect Dis 2016; 3: Suppl 1: 1425.
21. Date AA, Kyaw MH, Rue AM, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumpsrubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008; 197: 1662-8.
22. Fiebelkorn AP, Coleman LA, Belongia EA, et al. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis 2014; 1(3): Ofu094.
23. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine 2008; 26: 3601-7.
24. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: A case control study. Vaccine 2005; 23: 4070-4.
25. Snijders BE, van Lier A, van de Kassteele J, et al. Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine 2012; 30: 2999-3002.
26. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2015. MMWR Morb Mortal Wkly Rep 2016; 65: 850-8.
27. Parker Fiebelkorn A, Barskey A, Hickman C, Bellini W. Mumps. In: Manual for the surveillance of vaccine-preventable diseases. Atlanta: Centers for Disease Control and Prevention, 2012 (https:/ / www .cdc .gov/ vaccines/ pubs/ surv-manual/ chpt09-mumps .html).